News | Page 17 | Weill Department of Medicine

Dr. Iliev Publishes Key Finding on Fungal Species in Tumors in Cell

Dr. Iliyan IlievOn the heels of receiving a Lloyd J. Old Star Program Grant for the study of the role of fungi in cancer development and immunotherapy, Dr. Iliyan Iliev has published a paper in Cell (September 29) that has revealed that the presence of some fungal species in tumors predicts—and may even help drive—worse cancer outcomes. This key breakthrough holds promise for developing diagnostic tests for the prediction of cancer progression and therapy.Dr. Iliev, Associate Professor of... Read More

New Automated Screening Tool for Idiopathic Pulmonary Fibrosis (IPF) Utilizes Electronic Medical Records

Dr. Fernando MartinezDr. Fernando Martinez has co-authored a paper in Nature Medicine that describes a newly discovered automated tool for identifying patients at high risk for having or developing IPF.IPF, which causes progressive scarring of the lungs due to chronic lung inflammation, is usually fatal because it tends to be diagnosed late in the process when treatments are less effective. Dr. Martinez and colleagues have found that their new screening tool, utilizing electronic medical... Read More

Dr. Glesby Appointed as WDOM’s Vice Chair for Mentoring and Faculty Development

Dr. Marshall GlesbyMarshall Glesby, M.D., Ph.D. has been appointed as Vice Chair for Mentoring and Faculty Development in the Weill Department of Medicine (WDOM). In his new position, Dr. Glesby will build on the mentorship programs already present in the Department and Weill Cornell Medicine and develop innovative new efforts to enhance the professional growth of faculty at all levels. Additionally, he will focus on positioning faculty for promotion and play a critical role in the integration... Read More

Paige McMillan Appointed as WDOM’s Chief Administrative Officer Effective October 10, 2022

Paige McMillanPaige McMillan has been appointed as the Weill Department of Medicine's new Chief Administrative Officer (CAO) effective October 10th, 2022. Prior to joining Weill Cornell Medicine, Paige served as the Vice Chair of Administration and Finance, Department of Surgery, Mount Sinai Health System. She has also served as Administrative Director, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins, where she began her career as an administrative resident in... Read More

Led by Dr. Imperato-McGinley, the CTSC Receives $61.9 Million Grant from NIH (NCATS)

Dr. Julianne Imperato-McGinleyThe WDOM congratulates Dr. Julianne Imperato-McGinley on her continued service as Principal Investigator (and Founding Director) of the Clinical and Translational Science Center (CTSC).Dr. Imperato-McGinley has forged numerous breakthrough advances over the years serving as Principal Investigator of the CTSC at Weill Cornell Medicine, and with a recent $61.9 million award (funded until 2027) from the NIH’s National Center for Advancing Translational Sciences (NCATS... Read More

Dr. Hollenberg Presents Departmental Advances at Grand Rounds: Clinical Care, Research, Education

In what was his last presentation at Medicine Grand Rounds (September 14, 2022), Dr. Hollenberg provided a slide show of information that included the many advances of all divisions within the Weill Department of Medicine (WDOM). Dr. Hollenberg stepped down as Chair of the WDOM as of September 30, 2022.Dr. John P. Leonard will be serving as Interim Chair of the WDOM as of October 1, 1022. He is currently the department’s Executive Vice Chair, The Richard T. Silver Distinguished Professor of... Read More

Dr. Sonnenberg and Colleagues Publish Key Finding in Nature: How Immune System Tolerates Friendly Gut Bacteria

Dr. Gregory SonnenbergBuilding upon his laboratory’s many discoveries centered around ILC3s, Dr. Gregory Sonnenberg has published another breakthrough in Nature (September 7, 2022).Serving as senior author, Dr. Sonnenberg and team have defined a novel pathway involving the group 3 innate lymphoid cells (ILC3s) and interactions between T cells and a transcription factor known as RORγt. Specifically, the team has determined that the mechanism involved plays an essential role in establishing... Read More

New Directors at the Sandra and Edward Meyer Cancer Center

Dr. Jedd WolchokDr. Jedd Wolchok has been appointed as the Meyer Director of the Sandra and Edward Meyer Cancer Center and Dr. Taha Merghoub as Deputy Director, effective September 12.Jedd Wolchok, M.D., Ph.D., Professor of Medicine, Division of Hematology and Medical Oncology, is an internationally renowned medical oncologist whose innovations in immunotherapy have revolutionized melanoma treatment. Dr. Wolchok’s advances have included participating in the clinical development of the U.S. Food... Read More

In Memory of Dr. Richard J. Mahler

The WDOM announces the passing of Dr. Richard J. Mahler on August 6, 2022. An expert in the field of endocrinology, Dr. Mahler was beloved by patients, trainees, and colleagues alike. His thriving clinical practice was divided between diabetes and internal medicine. He was frequently listed in Best Doctors of New York, was a Member of The Harvey Society, and served on the Scientific Advisory Board of the Clinical and Translational Science Center at Weill Cornell Medicine. Dr. Mahler loved... Read More

Weill Department of Medicine Annual Report

The Joan and Sanford I. Weill Department of Medicine is pleased to present its Annual Report that covers activities spanning calendar year 2021. The report includes divisional news, faculty honors and awards, leadership biographies, information on our residency training program in internal medicine, as well as featured news stories. This year’s feature stories include the innovative work of four of our faculty: Drs. Gregory Sonnenberg, Erica Phillips, Brad Jones, and Lishomwa “Lish” Ndhlovu.... Read More